Is Curing Disease Simply Not Profitable Enough? (Listen Live)

Published: May 11, 2018

Big Pharma Greed

In his recent article, It's Official! Curing Patients Is Bad for Business, pharmaceutical consultant Milton Packer MD says "Pharmaceutical companies are developing new drugs in only two therapeutic areas these days — cancer and rare diseases. Why? These are the only therapeutic areas where exorbitant pricing is tolerated by payers."

Dr. Teitelbaum will appear on the nationally syndicated Jim Bohannon Show this Wednesday, May 16 at 11:00 pm ET to discuss this new and unfortunate direction of big pharma and medicine, where curing disease simply doesn't pay (you can call in to the show with questions and comments). Dr. T will also discuss tips on how to survive and thrive in our current healthcare system

The show is syndicated on hundreds of stations nationwide. Visit the Jim Bohannon Show website to find a radio station in your area. The episode will also be posted to the Bohannon website as a podcast that you can listen to later if you can't tune in for the live discussion.

Jacob Teitelbaum, MD

is one of the world's leading integrative medical authorities on fibromyalgia and chronic fatigue. He is the lead author of eight research studies on their effective treatments, and has published numerous health & wellness books, including the bestseller on fibromyalgia From Fatigued to Fantastic! and The Fatigue and Fibromyalgia Solution. Dr. Teitelbaum is one of the most frequently quoted fibromyalgia experts in the world and appears often as a guest on news and talk shows nationwide including Good Morning America, The Dr. Oz Show, Oprah & Friends, CNN, and Fox News Health.

e-mail icon
Facebook icon
Twitter icon
Google icon
LinkedIn icon